|
Incidence of Hepatocellular Carcinoma in Patients with HCV-associated
Cirrhosis Treated with Direct-Acting Antiviral Agents.
Calvaruso V, Cabibbo G, Cacciola I, et al
Gastroenterology.
2018 Apr 12
Abstract
Interaction Between Hepatocellular Carcinoma and
Hepatitis C Eradication With Direct-acting Antiviral Therapy.
Konjeti VR, John BV.
Curr Treat Options Gastroenterol.
2018 Mar 22
Abstract
Effect of achieving sustained virological response before hepatitis C
virus-related hepatocellular carcinoma occurrence on survival and recurrence
after curative surgical microwave ablation.
Ryu T, Takami Y, Wada Y, et al
Hepatol Int.
2018 Feb 27
Abstract
Immunohistochemical and electron microscopic morphometric image analysis of
hepatocellular carcinoma in association of HCV infection.
Hassan S, Mansy SS, Tabak SA,
et al
Ultrastruct Pathol.
2018 Feb 9:1-11
Abstract
Hepatocellular carcinoma in the wait-listed patient with hepatitis C virus.
Prenner SB, Kulik L
Curr Opin Organ Transplant.
2018 Feb 5.
Abstract
Hepatitis C Virus mediated metastasis in hepatocellular carcinoma as a
therapeutic target for cancer management.
Khera L, Paul C, Kaul R.
Curr Drug Metab. 2018 Jan 28
Abstract
Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic
hepatitis C-affected patients treated with new drugs.
Cusato J, Boglione L, De Nicolò A, et al
Cancer Chemother Pharmacol. 2018 Jan 22
Abstract
Expression Analysis of Liver-Specific Circulating microRNAs in HCV-Induced
Hepatocellular Carcinoma in Egyptian Patients.
Mourad L, El-Ahwany E, Zoheiry M,
et al
Cancer Biol Ther. 2018
Jan 15:0.
Abstract
FULL-TEXR ARTICLE
Evaluating
screening approaches for hepatocellular carcinoma in a cohort of HCV related
cirrhosis patients from the Veteran's Affairs Health Care System
Tayob N, Richardson P, White DL
BMC Med Res Methodol.
2018 Jan 4;18(1):1
Paper
Hepatitis C-related hepatocellular carcinoma: diagnostic and therapeutic
management in HIV-patients.
D'Aleo F, Ceccarelli M, Venanzi Rullo E, et al
Eur Rev Med Pharmacol Sci.
2017 Dec;21(24):5859-5867.
Abstract
FULL-TEXT ARTICLE
Bridging
therapy effectiveness in the treatment of hepatocellular carcinoma prior to
orthotopic liver transplantation.
Rubinstein MM, Kaubisch A, Kinkhabwala M,
et al
J Gastrointest Oncol. 2017
Dec;8(6):1051-1055.
Paper
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma:
Special Reference to Sustained Virological Responses to Interferon Therapy.
Tanaka S, Tamori A, Takemura S, Hamano G, Ito T, Kawada
N, Kubo S.
Am Surg. 2017 Nov
1;83(11):1246-1255
Abstract
Levels of Cytokines in Serum Associate With Development of Hepatocellular
Carcinoma in Patients With HCV Infection Treated With Direct-acting
Antivirals.
Debes JD, van Tilborg M, Groothuismink ZMA, et al
Gastroenterology. 2017
Nov 1
Abstract
Hepatocellular Carcinoma after Achievement of Sustained Viral Response with
Daclatasvir and Asunaprevir in Patients with Chronic Hepatitis C Virus
Infection.
Ida H, Hagiwara S, Kono M, et al.
Dig Dis.
2017;35(6):565-573.
Abstract
Rising Rates of Hepatocellular Carcinoma Leading to Liver Transplantation in
Baby Boomer Generation with Chronic Hepatitis C, Alcohol Liver Disease, and
Nonalcoholic Steatohepatitis-Related Liver Disease.
Cholankeril G, Yoo ER, Perumpail RB, et al
Diseases. 2017 Sep
26;5(4).
Abstract
|HCV eradication induced by direct-acting
antiviral agents reduces the risk of hepatocellular
carcinoma.
Ioannou GN, Green PK, Berry K.
J Hepatol.
2017 Sep 5.
Abstract
Misdiagnosis of Hepatocellular Carcinoma in Patients
Receiving no Loco-regional Therapy Prior to Liver
Transplant: An Analysis of the OPTN Explant Pathology
Form.
Mehta N, Dodge JL, Roberts JP,
et
al
Clin
Transplant.
2017 Sep 7.
Abstract
Antiviral Therapy in Patients With Chronic Hepatitis
C-related Hepatocellular Carcinoma Responding to
Palliative Treatment.
Yu JH, Kim JK, Lee KS,Lee JI.
J Clin Gastroenterol.
2017 Aug 31
Abstract
Hepatocellular carcinoma risk following direct-acting
antiviral HCV therapy: A systematic review,
meta-analyses, and meta-regression.
Waziry R, Hajarizadeh B, Grebely J,et
a,
J Hepatol.
2017 Aug 9
Abstract
FULL-TEXT ARTICLE
The risks of hepatocellular carcinoma development after
HCV eradication are similar between patients treated
with peg-interferon plus ribavirin and direct-acting
antiviral therapy
Nagaoki Y, Imamura M, Aikata H,
PLoS One.
2017 Aug 10;12(8):e0182710.
Paper
Is early recurrence of hepatocellular
carcinoma in HCV cirrhotic patients affected by
treatment with direct-acting antivirals? A prospective
multicentre study.
Cabibbo G, Petta S,
Calvaruso V, Cacciola I, et al
Aliment Pharmacol Ther.
2017 Aug 9.
Abstract
Hepatocellular carcinoma in patients without advanced
fibrosis after eradication of HCV with
antiviral treatment.
Sánchez-Torrijos Y, Ternero Vega JE, Cepeda Franco C.
Rev Esp Enferm Dig.
2017 Aug 4;109.
Abstract
Circulating microRNAs panel as a diagnostic tool for
discrimination of HCV-associated hepatocellular
carcinoma
Ali HEA,
Abdel Hameed R, Effat H, et al
Clin
Res Hepatol Gastroenterol.
2017 Jul 24
Abstract
Identification of Potential Gene Network Associated with
HCV-Related Hepatocellular Carcinoma Using Microarray
Analysis.
Cheng Y, Ping J, Chen J.
Pathol
Oncol Res.
2017 Jul 1.
Abstract
Circulating Hypermethylated RASSF1A as a Molecular
Biomarker for Diagnosis of Hepatocellular Carcinoma
Mansour LA, El Raziky M, Mohamed
AA,
Asian Pac J Cancer Prev. 2017 Jun 25
Abstract
FULL-TEXT ARTICLE
On-treatment decrease of NKG2D correlates to early
emergence of clinically evident hepatocellular carcinoma
after interferon-free therapy for chronic hepatitis C
Chu PS, Nakamoto N, Taniki N, et al
PLoS One.
2017 Jun 15
Paper
Correlation of Serum Soluble
Fibrinogen-Like Protein 2 with Soluble FAS Ligand and
Interferon Gamma in Egyptian Hepatitis C Virus-Infected
Patients and Hepatocellular Carcinoma Patients.
El-Mesery M, El-Mowafy M, Elgaml A, et al
J Interferon Cytokine Res.
2017 Jun 13.|
Abstract
Potential ultrastructure
predicting factors for hepatocellular carcinoma in HCV
infected patients.
Mansy SS, El-Ahwany E, Mahmoud S, . et al
Ultrastruct Pathol.
2017 May 11:1-18.
Abstract
Outcome of All-Oral
Direct-Acting Antiviral Regimens on the Rate of
Development of Hepatocellular Carcinoma in Patients with
Hepatitis C Virus Genotype 1-Related Chronic Liver
Disease.
Ogata F, Kobayashi M, Akuta N, et al
Oncology. 2017
Apr 28.
Abstract
The Direct-Acting Antivirals for Hepatitis C Virus and
the Risk for Hepatocellular Carcinoma.
Chinchilla-López P, Qi X, Yoshida EM, Méndez-Sánchez N.
Ann Hepatol.
2017 May - Jun 2017;16(3):328-330.
Abstract
Impact
of Hepatitis C Virus Eradication on the Clinical Outcome
of Patients with Hepatitis C Virus-Related Advanced
Hepatocellular Carcinoma Treated with Sorafenib.
Kawaoka T, Aikata H, Teraoka Y, et al
Oncology.
2017 Mar 1.
Abstract
Challenges in Treatment of Hepatitis C among Patients
with Hepatocellular Carcinoma.
Saberi B, Dadabhai AS, Durand CM, Philosophe B,
et
al
Hepatology.
2017 Feb 17.
Abstract
Risk of End Stage Liver Disease, Hepatocellular
Carcinoma and Liver-Related Death By Fibrosis Stage in
the Hepatitis C Alaska Cohort.
Bruden DJ, McMahon BJ, Townshend-Bulson L, et al
Hepatology.
2017 Feb 13.
Abstract
Hepatocellular Carcinoma Decreases the Chance of
Successful Hepatitis C Virus Therapy with Direct-Acting
Antivirals.
Prenner S, VanWagner LB, Flamm SL
J Hepatol.
2017 Feb 1..
Abstract
Risk of hepatitis C virus related hepatocellular
carcinoma between subjects with spontaneous and
treatment-induced viral clearance
Huang
CF, Yeh ML, Huang CI, et al
Oncotarget.
2017 Feb 1.
Abstract
A meta-analysis of single HCV-untreated arm of studies evaluating
outcomes after curative treatments of HCV-related hepatocellular
carcinoma.
Cabibbo G, Petta S, Barbàra M,
et al
Liver Int.
2017 Jan 6
Abstract
Hepatocellular Carcinoma is the Most Common Indication for Liver
Transplantation and Placement on the Waitlist in the United States.
Yang JD, Larson JJ, Watt KD, et al
Clin Gastroenterol Hepatol. 2016 Dec 21.
Abstract
Evaluation of serum levels and significance of soluble CD40 ligand in
screening patients with hepatitis C virus-related hepatocellular carcinoma.
Eltaher SM, El-Gil R,
Fouad N,
et al
East Mediterr Health J.
2016 Nov 2;22(8):603-610.
Abstract
Hepatocellular carcinoma recurrence in patients with curative
resection or ablation: impact of HCV eradication does not depend on the use
of interferon.
Petta S, Cabibbo G, Barbara M,
et al
Aliment Pharmacol Ther.
2016 Oct 28.
Abstract
Identification
of Circulating Protein Biomarkers in Patients with Hepatocellular Carcinoma
Concomitantly Infected with Chronic Hepatitis C Virus.
Abdel-Wahab AA, El-Halawany MS, Emam AA,
et al
Biomarkers. 2016 Oct
28:1-26.
Abstract
Infection
With Hepatitis C Virus Genotype 3 is an Independent Risk Factor for
End-stage Liver Disease, Hepatocellular Carcinoma, and Liver-related Death.
McMahon BJ, Bruden D, Townshend-Bulson L, et al
Clin Gastroenterol Hepatol.
2016 Oct 17.
Abstract
Comparing clinical presentations, treatments and outcomes of hepatocellular
carcinoma due to Hepatitis C and Non Alcoholic Fatty Liver Disease.
Than NN, Ghazanfar A, Hodson J,
QJM. 2016
Sep 10.
Abstract
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in
Patients With Hepatitis C Cirrhosis.
Yang JD, Mohamed HA, Cvinar JL,
Am J Gastroenterol.
2016 Aug 16.
Abstract
Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key
regulator of hepatocellular carcinoma.
Vallianou I, Dafou D, Vassilaki N, Mavromara P,
Int J Biochem Cell Biol.
2016 Jul 28.
Abstract
Molecular mechanisms of Hepatitis C virus-induced hepatocellular carcinoma.
Vescovo T, Refolo G, Vitagliano G,
et al
Clin Microbiol Infect. 2016 Jul
28
Abstract
Nomogram for individualized prediction of hepatocellular
carcinoma occurrence in HCV-cirrhosis (ANRS CO12 CirVir).
Ganne-Carrié N, Layese R, Bourcier V, et al
Hepatology. 2016 Jun 27.
Abstract
Diabetes and cirrhosis are risk factors for hepatocellular
carcinoma after successful treatment of chronic hepatitis C.
Hedenstierna M, Nangarhari A, Weiland O, Aleman S.
Clin Infect Dis. 2016 Jun 9
Abstract
Acute exacerbation of hepatitis C in hepatocellular carcinoma patients
receiving chemotherapy.
Lin JW, Chang ML, Hsu CW,
J
Med Virol. 2016 Jun 8.
Abstract
Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be
susceptible to oncolytic vesicular stomatitis virus through down-regulation
of HDAC4.
Moon J, Kaowinn S, Cho IR,
et al
Biochem Biophys Res Commun.
2016 May 2.
Abstract
Dynamic α-fetoprotein, platelets and AST-to-platelet ratio index predict
hepatocellular carcinoma in chronic hepatitis C patients with sustained
virological response after antiviral therapy.
Wu CK, Chang KC, Hung CH, et al
J Antimicrob Chemother.
2016 Apr 12.
Abstract
How have the recent advances in antiviral therapy impacted the management of
virus-related hepatocellular carcinoma?
Wang CC, Kao JH.
Expert Opin Pharmacother. 2016 Feb
1.
Abstract
FULL-TEXT ARTICLE
Inflammatory pseudotumor of the liver occurring during the course of
hepatitis C virus-related hepatocellular carcinoma treatment: A case report
Honmyo N, Kobayashi T, Tashiro
H, et
al
Int J Surg Case Rep.
2016 Jan 22;20:96-100
Paper
Direct costs of care for hepatocellular carcinoma in patients
with hepatitis C cirrhosis.
Tapper EB, Catana AM, Sethi N, et al
Cancer. 2015 Dec
Abstract
Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma
in Chronic Hepatitis C Virus Patients: A Systematic Review.
Dyal HK, Aguilar M,
Bartos G, et al
Dig Dis Sci.
2015 Dec 24
Abstract
Impact of Hepatitis C Virus Infection on Hepatocellular Carcinoma.
Tholey DM, Ahn J.
Gastroenterol Clin North Am.
2015 Dec;44(4):761-73
Abstract
Development of hepatocellular carcinoma in patients with
hepatitis C virus infection who achieved sustained virological response
following interferon therapy: A large-scale, long-term cohort study.
Nagaoki Y, Aikata
H, Nakano N, , et al
J Gastroenterol Hepatol. 2015 Nov
19.
Abstract
Role of Locoregional Therapy and Predictors for Dropout in
Patients with Hepatocellular Carcinoma Listed for Liver Transplantation.
Sheth RA, Patel MS,
Koottappillil B,
et al
J Vasc Interv Radiol.
2015 Sep 23.
Abstract
Subcutaneous metastasis - the first sign of hepatocellular
carcinoma in chronic virus C hepatitis patient - Case report.
Ciortescu I,
Rotariu A, Cozma DM,
et
al
J Med
Life. 2015 Jul-Sep;8(3):361-4.
Abstract
Is there a survival benefit in interventional radiology for hepatocellular
carcinoma in patients with Child-Pugh C liver cirrhosis?: A multicenter
study.
Hiraoka A, Kumada T, Michitaka K, et al
Hepatol Res. 2015 Aug 29.
.
Abstract
Hepatocellular Carcinoma in Patients with a Sustained
Response to Anti-Hepatitis C Therapy.
D'Ambrosio R, Della
Corte C, Colombo M.
Int J Mol Sci. 2015 Aug 19;16(8):19698-19712.
Abstract
Hepatitis C virus-induced hepatocellular carcinoma.
Goossens N, Hoshida Y.
Clin Mol Hepatol. 2015
Jun;21(2):105-14.
Abstract
Residual risk of hepatocellular carcinoma after HCV
eradication: more than meets the eye.
Macaluso FS, Calvaruso V, Craxì A.
Future Microbiol. 2015 Jun;10:977-88.
Abstract
A hepatic stellate cell gene expression signature associated
with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after
curative resection.
Zhang DY, Goossens N, Guo J, et al
Gut. 2015 Jun 4.
Abstract
Systematic Review: Impact of Interferon-based Therapy on HCV-related
Hepatocellular Carcinoma.
Hsu CS, Chao YC, Lin HH, et al
Sci Rep. 2015 May
12;5:9954.
Abstract
Hepatitis C Virus Infection, Antiviral Therapy, and Risk of Hepatocellular
Carcinoma.
Hsu YC, Wu CY, Lin JT.
Semin Oncol. 2015
Apr;42(2):329-338.
Abstract
A Comparison of Patients With Hepatitis B- or Hepatitis
C-Based Advanced-Stage Hepatocellular Carcinoma.
Carr BI, Guerra V, Steel JL,
Lu SN.
Semin Oncol. 2015 Apr;42(2):309-315
Abstract
FULL-TEXT ARTICLE
Viruses in
cancer cell plasticity: the role of hepatitis C virus in hepatocellular
carcinoma.
Hibner U, Grégoire D.
Contemp Oncol (Pozn). 2015;19(1A):A62-7.
Paper
Risk Factors of HCC Development in Non-cirrhotic Patients
with Sustained Virologic Response for Chronic HCV Infection.
Toyoda H, Kumada T, Tada T, et al
J Gastroenterol Hepatol.
2015 Feb 13.
Abstract
Genetic polymorphism of IL-23R influences susceptibility to
HCV-related hepatocellular carcinoma.
Labib HA, Ahmed HS, Shalaby SM,et
al
Cell Immunol. 2015
Jan 28.
Abstract
Liver resection for hepatocellular carcinoma in patients with
metabolic syndrome: A multicenter matched analysis with HCV-related HCC.
Viganò L, Conci S, Cescon M, Fava C, et al
J Hepatol.
2015 Jan 31
Abstract
FULL-TEXT ARTICLE
Surgical approach for hepatitis C
virus-related hepatocellular carcinoma.
Shindoh J,
Hashimoto M, Watanabe G.
et al
World
J Hepatol.
2015 Jan 27;7(1):70-7
Paper
Effect of pioglitazone on outcome following curative
treatment for hepatocellular carcinoma in patients with hepatitis C virus
infection: A prospective study.
Sumie S, Kawaguchi T, Kawaguchi A,. et
al
Mol Clin Oncol. 2015
Jan;3(1):115-120
Abstract
Laparoscopic left liver lobectomy for hepatocellular
carcinoma in a cirrhotic patient: a video report.
Levi Sandri GB, Vennarecci G, Santoro R, et al
Chin J Cancer Res.
2014 Dec;26(6):735-6..
Abstract
Recurrent genetic alterations in hepatitis C-associated
hepatocellular carcinoma detected by genomic microarray: a genetic, clinical
and pathological correlation study.
Liu YJ, Zhou Y, Yeh MM.
Mol Cytogenet.
2014 Nov 25;7(1):81.
Abstract
Increased DNA Damage in Hepatitis C Virus-Related
Hepatocellular Carcinoma.
Shawki SM, Meshaal SS, El Dash AS, et al
DNA Cell Biol.
2014 Sep 11
Abstract
Effect of Peginterferon alfa-2b and Ribavirin on Hepatocellular Carcinoma
Prevention in Older Patients with Chronic Hepatitis C.
Honda T, Ishigami M, Hayashi H, et al
J Gastroenterol Hepatol.
2014 Aug 5.
Abstract
FULL-TEXT
ARTICLE
Relationship
of ethnicity and overall survival in patients treated with sorafenib for
advanced hepatocellular carcinoma.
Peixoto RD, Renouf DJ, Gill S, et al
J
Gastrointest Oncol.
2014 Aug;5(4):259-64
Paper
Hepatocellular carcinoma treated by conventional
transarterial chemoembolization in field-practice: Serum sodium predicts
survival.
Biolato M, Miele L, Vero V, Racco
S, et al.
World J Gastroenterol. 2014 Jul 7;20(25):8158-65.
Abstract
Intent-to-Treat Analysis of Liver Transplant for
Hepatocellular Carcinoma in the MELD Era: Impact of Hepatitis C and Advanced
Status.
Hu Z, Li Z, Xiang J,
et al
Dig Dis Sci.
2014 Jul 10..
Abstract
FULL-TEXT
PDF ARTICLE
Effect
of pre- and post-treatment alpha-fetoprotein levels and tumor size on
survival of patients with hepatocellular carcinoma treated by resection,
transarterial chemoembolization or radiofrequency ablation: a retrospective
study.
Toro A, Ardiri A, Mannino M, Arcerito MC, et al
BMC Surg. 2014
Jul 4;14(1):40.
Paper
FULL-TEXT
ARTICLE
Effect of
Previous Interferon-based Therapy on Recurrence after Curative Treatment of
Hepatitis C Virus-related Hepatocellular Carcinoma.
Saito T, Chiba T, Suzuki E, Shinozaki M, et al
Int J Med Sci. 2014
May 7;11(7):707-12
Paper
Development of hepatocellular carcinoma in a non-cirrhotic,
long-term responder to antiviral therapy, chronic hepatitis C patient: what
kind of surveillance?
Bertolini E, Bassi F, Fornaciari G.
Ann Gastroenterol.
2013;26(1):80-83.
Abstract
Hepatocellular carcinoma screening in patients with
compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV
status improves survival: A modeling approach.
Mourad A, Deuffic-Burban S, Ganne-Carrié N, et al
Hepatology.
2014 Apr;59(4):1471-81.
Abstract
Incidence of hepatocellular carcinoma in hepatitis C cirrhotic patients with
and without HIV infection: a cohort study, 1999-2011.
Di Benedetto N, Peralta M, Alvarez E, et al
Ann
Hepatol. 2013 Jan-2014
Feb;13(1):38-44.
Abstract
A New Laboratory Based Algorithm to Predict Development of Hepatocellular
Carcinoma in Patients with Hepatitis C and Cirrhosis.
El-Serag HB, Kanwal F, Davila JA, et al
Gastroenterology. 2014
Jan 23
Abstract
Hepatocellular carcinoma in patients with chronic hepatitis C
virus infection in the Asia-Pacific region.
Kim MN, Kim BK, Han KH.
J Gastroenterol. 2013 Mar 6
Abstract |
General
Reports
HCV
Main Page